Top 10 Feature Articles of 2024

News
Article

The PharmTech Group editors present our most popular technical articles from 2024.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Pharmaceutical Technology® and Pharmaceutical Technology® Europe publishes independent, science-based articles and peer-reviewed papers from bio/pharmaceutical professionals working in the development and manufacturing of pharmaceuticals. In 2024, Pharmaceutical Technology® and Pharmaceutical Technology® Europe, via print issues, ebooks, and our website, PharmTech.com, published articles on topics ranging from development challenges, to manufacturing best practices, quality considerations, analytical approaches, and more.

The following are our picks for the ‘best of’ technical and peer-reviewed articles published in 2024, in no particular order:

For more peer-reviewed articles, please visit https://www.pharmtech.com/topic/peer-reviewed-research.
For the latest on drug development, please visit https://www.pharmtech.com/topic/drug-development.
To read in-depth manufacturing articles, visit https://www.pharmtech.com/topic/manufacturing.
A variety of quality-related topics can be found at https://www.pharmtech.com/topic/quality-gmps.
And the latest analytical technologies are discussed at https://www.pharmtech.com/topic/analytics.

For information on how to submit technical and peer-reviewed articles to Pharmaceutical Technology®, please view our submission guidelines at https://www.pharmtech.com/view/pharmaceutical-technology-submission-guidelines-and-editorial-calendars.

Recent Videos
Roger Viney, PhD, chief commercial officer for ICE Pharma
Behind the Headlines, episode 7
Behind the Headlines episode 6
CPHI Milan 2024: Highlighting the Benefits of Integrated Services
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content